QVirus™ Platform offers a comprehensive portfolio of oncolytic VACV services for the efficient design, development, manufacturing and analytical testing of virus vector products. So far, we have developed an efficient way to generate recombinant VACVs, including inserting and/or deleting GOI(s) in VACVs. We also provide customized oncolytic vaccinia virus and proof-of-concept validation study for the oncolytic virus.

https://qvirus.creative-bi...

Only people mentioned by creativebiogene in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Marcia Brady, click on at the bottom under it